Sunday, August 2, 2026

Intel Shares Gain 2% After Strong Earnings, But Soft Outlook Puts Pressure on Stock

Intel's earnings beat expectations, but a weaker forecast for the next quarter led to modest after-hours gains in stock price.

Want to See North Korea Up Close? There’s a New Spot for That

The Goseong Unification Observatory opens Mount Kumgang Observatory for veterans and students, offering views of North Korea's scenic areas.

North Korea Sanctions Lifted: What This Means for Humanitarian Aid in 2026

The Blue House supports Trump's humanitarian aid exemptions for North Korea, hoping for positive responses amid stalled dialogue.

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.

Yuhan to Receive $30 Million Milestone From European Launch of Lazertinib Combination Therapy

Yuhan Corporation receives a $30M milestone for Lazertinib's European launch, totaling $300M in payments, aiming for global healthcare leadership.

South Korean Team Develops Non-Invasive Device for Early Cardiovascular Risk Screening

South Korean researchers developed the Coronyzer, a non-invasive device predicting cardiovascular health via pulse wave analysis.

Samsung Epis Holdings Earns MSCI AA Rating in First Global ESG Assessment

Samsung Epis Holdings earns an AA ESG rating from MSCI, highlighting its commitment to sustainable management and biopharmaceutical growth.

U.S., Japan and China Advance Stem Cell Commercialization While Korea Works to Close Gaps

The global stem cell therapy market is rapidly growing, but South Korea faces challenges in commercialization compared to the U.S. and Japan.

MetaVia to Present DA-1726 Phase 1 Obesity Trial Data at EASL Congress 2026

Dong-A ST's Meta via will present DA-1726, a dual-action obesity treatment, at the EASL Congress 2026, showcasing promising clinical trial results.

South Korea Unveils New Blood Management Plan to Stabilize Supply Amid Demographic Shift

The Korean government is enhancing blood donation efforts, targeting younger donors and revising eligibility criteria to ensure stable supply.

The 2026 World Cup Could Bring More Than Soccer Fever, Korean Officials Warn

South Korean health authorities issue guidelines for infectious disease prevention for athletes and travelers at the 2026 FIFA World Cup.

This New DNA Detection Breakthrough Could Change How Scientists Study Cancer Risk

KRISS and Wright State University developed a precise platform to detect ultra-trace damaged DNA, enhancing cancer research and treatment evaluation.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

ezCaretech Expands AI Native HIS Strategy Through New Partnership With Huinno

ezCaretech is transforming into an AI-powered healthcare platform, partnering with Huinno to enhance medical AI services and workflows.

Wontech Expands Surgical Device Business With $2.2 Million HOLINWON Supply Deals in Uzbekistan and Indonesia

Wontech expands into surgical devices, securing $2.2M contracts in Asia for its advanced holmium laser technology.

Samsung Biologics Highlights CRDO and Organoid Platforms at PEGS Boston

Samsung Biologics showcased its CRDO capabilities at PEGS Boston, enhancing cancer drug development with innovative organoid technology.

Novo Nordisk’s Weekly Growth Hormone Sogroya Gains Reimbursement in Korea

Novo Nordisk's Sogroya gains insurance coverage, but market changes may be limited due to strong competitors and safety concerns.

This New Hospital Tech Can Spot Dangerous Changes Before Routine Checks Would Catch Them

Yonsei University Severance Hospital's PRISM system enables continuous patient monitoring, enhancing proactive healthcare and rapid response capabilities.

Top News

- Our Sponsors Ad -

Follow us